Ionis Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $156,719 | $452,049 | $131,612 | $226,576 |
Gross Profit | 154,381 | 447,898 | 130,112 | 222,746 |
EBITDA | -94,378 | 150,233 | -120,003 | -80,503 |
EBIT | -106,229 | 144,779 | -125,400 | -85,770 |
Net Income | -128,606 | 123,551 | -146,938 | -104,349 |
Net Change In Cash | 156,719 | 452,049 | 131,612 | 226,576 |
Free Cash Flow | -134,743 | 137,069 | -163,352 | -141,636 |
Cash | 338,341 | 297,304 | 264,192 | 242,077 |
Basic Shares | 160,758 | 182,331 | 158,735 | 158,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $705,138 | $787,647 | $587,367 | $810,456 |
Gross Profit | 693,923 | 778,514 | 573,251 | 799,614 |
EBITDA | -353,721 | -235,870 | -227,758 | -5,188 |
EBIT | -375,711 | -258,368 | -249,863 | -24,748 |
Net Income | -453,897 | -366,286 | -269,722 | -28,597 |
Net Change In Cash | 705,138 | 787,647 | 587,367 | 810,456 |
Cost of Revenue | -592,301 | 471,527 | ||
Free Cash Flow | -546,227 | -335,524 | -294,469 | 12,898 |
Cash | 242,077 | 399,266 | 276,472 | 2,115,000 |
Basic Shares | 149,514 | 143,190 | 141,848 | 141,021 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.61 |
2025-06-30 | $0.70 |
2025-03-31 | -$0.92 |
2024-12-31 | -$0.43 |
